Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
There are limited data regarding whether albuminuria and reduced estimated GFR (eGFR) are separate and independent risk factors for cardiovascular and renal events among individuals with type 2 diabetes. The Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) study examined the effects of routine BP lowering on adverse outcomes in type 2 diabetes. We investigated the effects of urinary albumin-to-creatinine ratio (UACR) and eGFR on the risk for cardiovascular and renal events in 10,640 patients with available data. During an average 4.3-yr follow-up, 938 (8.8%) patients experienced a cardiovascular event and 107 (1.0%) experienced a renal event. The multivariable-adjusted hazard ratio for cardiovascular events was 2.48 (95% confidence interval 1.74 to 3.52) for every 10-fold increase in baseline UACR and 2.20 (95% confidence interval 1.09 to 4.43) for every halving of baseline eGFR, after adjustment for regression dilution. There was no evidence of interaction between the effects of higher UACR and lower eGFR. Patients with both UACR >300 mg/g and eGFR <60 ml/min per 1.73 m(2) at baseline had a 3.2-fold higher risk for cardiovascular events and a 22.2-fold higher risk for renal events, compared with patients with neither of these risk factors. In conclusion, high albuminuria and low eGFR are independent risk factors for cardiovascular and renal events among patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both a reduction in eGFR and the presence of albuminuria are independently associated with an increased risk of CVD and mortality in a graded fashion [8,9].”
From Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: a review of their kidney and heart protection (2023) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
(2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00001 · Cited by 3,027
Mancia, G., Rosei, E. A., Cífková, R., DeBacker, G., Erdine, S. E., Fagard, R., Farsang, C., Heagerty, A. M., Kawecka-Jaszcs, K., Kiowski, W., et al. (2003) · Lirias · doi:10.1097/01.hjh.0000059051.65882.32 · Cited by 2,601
Self-citationGerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationRelation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
Anavekar, N. S., McMurray, J. J. V., Velazquez, E. J., Solomon, S. D., Kober, L., Rouleau, J.-L., White, H. D., Nordlander, R., Maggioni, A., Dickstein, K., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041365 · Cited by 1,917
Huxley, R., Barzi, F., & Woodward, M. (2006) · BMJ · doi:10.1136/bmj.38678.389583.7c · Cited by 1,534
Self-citationGoodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Epidemiology: Study Design and Data Analysis
(2006) · Technometrics · doi:10.1198/tech.2006.s407 · Cited by 788
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Circulation · doi:10.1161/01.cir.0000139860.33974.28 · Cited by 750
Self-citationIbsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154082.72286.2a · Cited by 562 · cited 1×
“Previous vascular disease (n % ) history of macrovascular disease 3394 (32) history of myocardial infarction 1250 (12) history of stroke 971 (9) Other major risk factors HbA1c (%; mean SD ) 7.”
BackgroundSelf-citationValmadrid, C. T., Klein, R., Moss, S. E., & Klein, B. E. K. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1093 · Cited by 472
Easton, D. F., Peto, J., & Babiker, A. G. A. G. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100703 · Cited by 433
Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer, C. D. A., & Smulders, Y. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121288 · Cited by 428
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Jefferson, J. A., Shankland, S. J., & Pichler, R. H. (2008) · Kidney International · doi:10.1038/ki.2008.128 · Cited by 419
Garg, A. X., Kiberd, B. A., Clark, W. F., Haynes, R. B., & Clase, C. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00356.x · Cited by 355
Arima, H., Chalmers, J., Woodward, M., Anderson, C., Rodgers, A., Davis, S., MacMahon, S., & Neal, B. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226212.34055.86 · Cited by 327
Self-citationIrie, F., Iso, H., Sairenchi, T., Fukasawa, N., Yamagishi, K., Ikehara, S., Kanashiki, M., Saito, Y., Ota, H., & Nose, T. (2006) · Kidney International · doi:10.1038/sj.ki.5000284 · Cited by 320
Astor, B. C., Hallan, S. I., Miller, E. R., Yeung, E., & Coresh, J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn033 · Cited by 312
Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients
Caramori, M. L., Fioretto, P., & Mauer, M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1036 · Cited by 301
Asia Pacific Cohort Studies Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.2.360 · Cited by 300
Hallan, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2490 · Cited by 284
Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
de Galan, B. E., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C.-E., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070667 · Cited by 271
Self-citationBarzi, F. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh175 · Cited by 261
Self-citationComparison of baseline and repeated measure covariate techniques in the Framingham heart study
Cupples, L. A., D'Agostino, R. B., Anderson, K., & Kannel, W. B. (1988) · Statistics in Medicine · doi:10.1002/sim.4780070122 · Cited by 254
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
Perkovic, V., Verdon, C., Ninomiya, T., Barzi, F., Cass, A., Patel, A., Jardine, M., Gallagher, M., Turnbull, F., Chalmers, J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050207 · Cited by 239
Self-citationProgressive Decline in Renal Function in Diabetic Patients With and Without Albuminuria
Tsalamandris, C., Allen, T. J., Gilbert, R. E., Sinha, A., Panagiotopoulos, S., Cooper, M. E., & Jerums, G. (1994) · Diabetes · doi:10.2337/diab.43.5.649 · Cited by 195
Self-citationTonelli, M., Jose, P., Curhan, G., Sacks, F., Braunwald, E., & Pfeffer, M. (2006) · BMJ · doi:10.1136/bmj.38814.566019.2f · Cited by 193
Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
Diamond, J. R. (1991) · PubMed · Cited by 184
Brantsma, A. H., Bakker, S. J. L., Hillege, H. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., & for the PREVEND Study Group (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn356 · Cited by 173
Proteinuria and Stroke: A Meta-analysis of Cohort Studies
Ninomiya, T., Perkovic, V., Verdon, C., Barzi, F., Cass, A., Gallagher, M., Jardine, M., Anderson, C. S., Chalmers, J. P., Craig, J. C., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.032 · Cited by 163
Self-citationLaeis, P., Püchler, K., & Kirch, W. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106001-00004 · Cited by 156
MacIsaac, R. J., Panagiotopoulos, S., McNeil, K. J., Smith, T. J., Tsalamandris, C., Hao, H., Matthews, P. G., Thomas, M. C., Power, D. A., & Jerums, G. (2006) · Diabetes Care · doi:10.2337/dc05-1788 · Cited by 132
Bigazzi, R., Bianchi, S., Nenci, R., Baldari, D., Baldari, G., & Campese, V. M. (1995) · PubMed · Cited by 122
Foster, M. C., Hwang, S.-J., Larson, M. G., Parikh, N. I., Meigs, J. B., Vasan, R. S., Wang, T. J., Levy, D., & Fox, C. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1386 · Cited by 116
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region
(2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280dce59e · Cited by 94
Cirillo, M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.617 · Cited by 93
Saab, P. G., Llabre, M. M., Ma, M., DiLillo, V., McCalla, J. R., Fernander-Scott, A., Copen, R., Gellman, M., & Schneiderman, N. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00003 · Cited by 63
Assessment and management of hypertension in patients with type 2 diabetes
Thomas, M. C., & Atkins, R. C. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01696.x · Cited by 12
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Self-citation2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationKDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citation
Metadata
- Authors
- Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., Mogensen, C.-E., Cooper, M., Marre, M., Williams, B., Hamet, P., Mancia, G., Woodward, M., MacMahon, S., & Chalmers, J.
- Affiliations
- The University of Sydney (AU)
- Imperial College London (GB)
- Aarhus University (DK)
- Baker Heart and Diabetes Institute (AU)
- Hôpital Bichat-Claude-Bernard (FR)
- Radboud University Medical Center (NL)
- Corresponding author
- Ninomiya, Toshiharu
- Perkovic, Vlado
- Zoungas, Sophia
- Pillai, Avinesh
- Jardine, Meg
- Patel, Anushka
- Cass, Alan
- Neal, Bruce
- Williams, Bryan
- Woodward, Mark
- MacMahon, Stephen
- Chalmers, John
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2009-08
- Volume
- 20
- Issue
- 8
- Pages
- 1813-1821
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC2723977
- OpenAlex
- W2116077357
- Cited by
- 965
- References
- 43
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 47 · 2023: 57 · 2022: 50 · 2021: 75 · 2020: 71 · 2019: 57 · 2018: 60 · 2017: 52 · 2016: 62 · 2015: 50 · 2014: 62 · 2013: 70 · 2012: 49
- FWCI
- 42.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- albuminuria, albumin-creatinine ratio, estimated glomerular filtration rate, type 2 diabetes, cardiovascular events, renal events, cardiovascular risk factors, renal risk factors, ADVANCE trial, blood pressure reduction, regression dilution
- MeSH terms
- Aged, Albuminuria, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Risk Factors, Randomized Controlled Trials as Topic, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.